Mayland Chang

6.2k citations

109 papers · 4.7k indexed · 1 hit paper · h-index 37

Impact in

Rehabilitation top 0.5%
- Wound Healing and Treatments
Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria

Papers in

Cancer Research 42
- Protease and Inhibitor Mechanisms 41
Molecular Medicine 12
- Antibiotic Resistance in Bacteria 12

Co-authors: Shahriar Mobashery Trung T. Nguyen J.A. Hermoso William R. Wolter Mark A. Suckow Valerie A. Schroeder Mijoon Lee Jennifer Fishovitz
Journals: Journal of Medicinal Chemistry (9 papers)ACS Pharmacology & Translational Science (7 papers)Journal of the American Chemical Society (6 papers)ACS Medicinal Chemistry Letters (6 papers)Antimicrobial Agents and Chemotherapy (5 papers)
Partner nations: United States Spain Germany

In The Last Decade

Mayland Chang

105 papers receiving 4.6k citations

Hit Papers

align trajectories log scale

Strategy for Treatment of Infected Diabetic Foot Ulcers 2021 · 502 citations

Peers

Countries citing papers authored by Mayland Chang

Since Specialization

Citations

This map shows the geographic impact of Mayland Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayland Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayland Chang more than expected).

Fields of papers citing papers by Mayland Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayland Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayland Chang. The network helps show where Mayland Chang may publish in the future.

Co-authors

The 25 scholars most cited alongside Mayland Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mayland Chang Line = papers co-authored together Mayland Chang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Reactions of SleC, Its Structure and Inhibition in Mitigation of Spore Germination in Clostridioides difficile Journal of the American Chemical Society ·Choon Kim, Rafael Molina, Mijoon Lee, سید مصطفی سراب زاده, Eka Yulianti Alwi, Yuanyuan Qian, Biruk Tesfaye Birhanu, Dušan Hesek, J.A. Hermoso, Mayland Chang, Shahriar Mobashery	2025	0
2	Restoring susceptibility to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus Nature Chemical Biology ·Van Trung Nguyen, Biruk Tesfaye Birhanu, William Hayter, Choon Kim, Duncan Smith, Eka Yulianti Alwi, Entessar Abd ALrassol, Y. Eshaq, Valerie A. Schroeder, Fredriksen, 志超张, 晴美石堂, Graziela Garrido Mori, A Marin Gracia, Mijoon Lee, Jed F. Fisher, J.A. Hermoso, Mayland Chang, Shahriar Mobashery	2024	8
3	Matrix metalloproteinase profiling and their roles in disease RSC Advances ·Mayland Chang	2023	25
4	Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy ACS Pharmacology & Translational Science ·Ravi Rani, Giorgia Manzo, Charlotte K. Hind, Jeshina Janardhanan, 邱建林, Lea Projer, Rashna D. Balsara, Melanie Clifford, В. Н. Самойлова, Brienna Williams, І. В. Боцула, Alejandro Gonzalez, Tam T. T. Bui, Victoria A. Ploplis, Francis Castellino, Albert Siryaporn, Mayland Chang, J. Mark Sutton, A. James Mason, Shaun W. Lee	2020	14
5	Molecular mechanisms of IL-33–mediated stromal interactions in cancer metastasis JCI Insight ·Patrik Andersson, Yunlong Yang, Kayoko Hosaka, Yin Zhang, Carina Fischer, Harald Braun, Shuzhen Liu, Guohua Yu, Shihai Liu, Rudi Beyaert, Mayland Chang, Qi Li, Yihai Cao	2018	96
6	Expression of active matrix metalloproteinase-9 as a likely contributor to the clinical failure of aclerastide in treatment of diabetic foot ulcers European Journal of Pharmacology ·Trung T. Nguyen, Derong Ding, William R. Wolter, Matthew M. Champion, Dušan Hesek, Mijoon Lee, Rocío L. Pérez, Valerie A. Schroeder, Mark A. Suckow, Shahriar Mobashery, Mayland Chang	2018	19
7	Selective small-molecule inhibitors as chemical tools to define the roles of matrix metalloproteinases in disease Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Eliška Fidlerová, Mayland Chang	2017	22
8	The oxadiazole antibacterials Current Opinion in Microbiology ·Jeshina Janardhanan, Mayland Chang, Shahriar Mobashery	2016	45
9	Discovery of Antibiotic ( E )-3-(3-Carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3 H )-one Journal of the American Chemical Society ·Renee A. Bouley, Malika Kumarasiri, Zhihong Peng, Lisandro H. Otero, Wei Song, Mark A. Suckow, Valerie A. Schroeder, William R. Wolter, Elena Lastochkin, Nuno T. Antunes, Hualiang Pi, Sergei B. Vakulenko, J.A. Hermoso, Mayland Chang, Shahriar Mobashery	2015	119
10	Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse PLoS ONE ·Bridgette D. Semple, Linda J. Noble‐Haeusslein, Major Gooyit, Christo Siby, Zhihong Peng, Trung T. Nguyen, Valerie A. Schroeder, Mark A. Suckow, Mayland Chang, Jacob Raber, Alpa Trivedi	2015	15
11	Exploration of the structure–activity relationship of 1,2,4-oxadiazole antibiotics Bioorganic & Medicinal Chemistry Letters ·Derong Ding, Marc A. Boudreau, Erika Leemans, Edward Spink, Takao Yamaguchi, Sebastián A. Testero, Peter I. O’Daniel, Elena Lastochkin, Mayland Chang, Shahriar Mobashery	2015	36
12	How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function Proceedings of the National Academy of Sciences ·Lisandro H. Otero, A. Rojas-Altuve, Leticia I. Llarrull, César Carrasco‐López, Malika Kumarasiri, Elena Lastochkin, Jennifer Fishovitz, M. Michele Dawley, Dušan Hesek, Mijoon Lee, Jarrod W. Johnson, Jed F. Fisher, Mayland Chang, Shahriar Mobashery, J.A. Hermoso	2013	208
13	Selective Inhibition of Matrix Metalloproteinase-9 Attenuates Secondary Damage Resulting from Severe Traumatic Brain Injury PLoS ONE ·Frank P. Stetz, Ranaldi F., Major Gooyit, Shanyan Chen, З. В. Кучерова, Jennifer M. Walker, Chun‐yang Zhang, A. Wasilewski, Anjum Hussain, E. de G. ALVES FILHO, S nbspRathika, Valerie A. Schroeder, Mark A. Suckow, Ágnes Simonyi, Grace Y. Sun, Shahriar Mobashery, Jiankun Cui, Mayland Chang, Zezong Gu	2013	96
14	Structural Basis for Carbapenemase Activity of the OXA-23 β-Lactamase from Acinetobacter baumannii Chemistry & Biology ·Clyde A. Smith, Nuno T. Antunes, Nichole K. Stewart, Márta Tóth, Malika Kumarasiri, Mayland Chang, Shahriar Mobashery, Sergei B. Vakulenko	2013	103
15	Exploring the functional space of thiiranes as gelatinase inhibitors using click chemistry ARKIVOC ·Sebastián A. Testero, Leticia I. Llarrull, Jed F. Fisher, Mayland Chang, Shahriar Mobashery	2011	9
16	Role of Matrix Metalloproteinases and Therapeutic Benefits of Their Inhibition in Spinal Cord Injury Neurotherapeutics ·Haoqian Zhang, Mayland Chang, Evangelos Stefanou, D. Michele Basso, Linda J. Noble‐Haeusslein	2011	133
17	A Potent Gelatinase Inhibitor with Anti‐Tumor‐Invasive Activity and its Metabolic Disposition Chemical Biology & Drug Design ·Mijoon Lee, Giuseppe Celenza, Bill Boggess, Lakkaraju Datha Sri Laasya, Qicun Shi, Márta Tóth, M. Margarida Bernardo, William R. Wolter, Mark A. Suckow, Dušan Hesek, B.C. Noll, Rafael Fridman, Shahriar Mobashery, Mayland Chang	2009	32
18	Effect of Ablation or Inhibition of Stromal Matrix Metalloproteinase-9 on Lung Metastasis in a Breast Cancer Model Is Dependent on Genetic Background Cancer Research ·Michelle D. Martin, Kathy J. Carter, Shalaka Anil Khilari, Mayland Chang, Shahriar Mobashery, Sophie Thiolloy, Conor C. Lynch, Lynn M. Matrisian, Barbara Fingleton	2008	99
19	Inhibition of human prostate cancer growth and osteolysis in a bone metastasis model by a mechanism-based specific gelatinase inhibitor (SB-3CT) Cancer Research ·R. Daniel Bonfil, Aaron Sabbota, Sanaa Nabha, Zhong Dong, J. Carlos Trindade Filho, Sreenivasa R. Chinni, Wanming Zhang, Cong Xiao-feng, Hak-Gyeong Kim, Mayland Chang, Shahriar Mobashery, Michael L. Cher, Rafael Fridman	2005	1
20	Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats. PubMed ·Mayland Chang, Shushu Yang, Jonas Woelki, Judith K. Linn, P E Sanders, M J Hauer, Paul E. Fagerness	1997	12

About Mayland Chang

Mayland Chang is a scholar working on Cancer Research, Molecular Medicine, Rehabilitation, Infectious Diseases and Organic Chemistry, having authored 109 papers that have together received 4.7k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (41 papers), Antimicrobial Resistance in Staphylococcus (19 papers), Peptidase Inhibition and Analysis (19 papers), Wound Healing and Treatments (13 papers), Antibiotic Resistance in Bacteria (12 papers), Cancer therapeutics and mechanisms (11 papers), Quinazolinone synthesis and applications (10 papers) and Signaling Pathways in Disease (9 papers). The work is most often cited by research in Rehabilitation (745 citations), Molecular Medicine (537 citations), Cancer Research (847 citations), Occupational Therapy (156 citations) and Organic Chemistry (1.0k citations). Mayland Chang has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Shahriar Mobashery, Trung T. Nguyen, J.A. Hermoso, William R. Wolter, Mark A. Suckow, Valerie A. Schroeder, Mijoon Lee, Jennifer Fishovitz, Elena Lastochkin and Major Gooyit. Their work appears in journals such as Journal of Medicinal Chemistry, ACS Pharmacology & Translational Science, Journal of the American Chemical Society, ACS Medicinal Chemistry Letters and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact